权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Phenotypic and functional characterization of primary human lymphoid dendritic cells, with a focus on XCR1+ DC

原代人淋巴树突状细胞的表型和功能特征，重点是 XCR1 DC

基本信息

批准号：
202056988
负责人：
Professor Dr. Richard Kroczek
金额：
--
依托单位：
Projektgruppe 1: Immunologische Abwehrmechanismen
依托单位国家：
德国
项目类别：
Research Grants
财政年份：
2011
资助国家：
德国
起止时间：
2010-12-31 至 2015-12-31
项目状态：
已结题

来源：
https://gepris.dfg.de/gepris/projekt/202056988?language=en
关键词：
Phenotypic functional characterization primary human

项目摘要

Dendritic cells (DC) are cells in the immune system, which “professionally” take up protein antigens and present it to T cells. The ensuing “dialogue” between T cells and DC is pivotal for the decision between “immunity” and “tolerance” to an antigen. While important advances have been made in the understanding of DC subset function in the mouse, information on primary human conventional DC remained surprisingly scarce, apparently because of their very low numbers in blood and lymphoid tissues and the lack of markers. Instead, almost all experiments in the human have been performed with DC generated from monocytes in vitro, cells which only incompletely reflect primary DC. Very recently, we characterized a subset-specific DC surface molecule (XCR1 receptor), additional molecules on DC were defined by others. These advances, together with improved cell isolation techniques, allow now to better characterize primary human DC. In the project, we intend to refine the current initial understanding of primary human blood DC for antigen (cross-) presentation to T cells and to define the basic phenotype and immune function of human DC resident in lymphoid tissues and peripheral organs. This information will show whether the concepts developed in the mouse also hold true for human DC in health and (autoimmune) disease. The gained knowledge is a prerequisite for the future development of novel vaccines by us and others, in which cytotoxic immunity to tumors and intracellular pathogens is to be achieved by direct targeting of antigen to XCR1+ DC in vivo.

树突状细胞（DC）是免疫系统中的细胞，它“专业地”吸收蛋白质抗原并将其呈递给T细胞。随后T细胞和DC之间的“对话”对于决定对抗原的“免疫”和“耐受”至关重要。虽然在了解小鼠DC亚群功能方面取得了重要进展，但关于原发性人类常规DC的信息仍然非常少，这显然是因为它们在血液和淋巴组织中的数量非常少，而且缺乏标记物。相反，几乎所有的人体实验都是用体外单核细胞产生的DC进行的，这些细胞只能不完全反映原代DC。最近，我们表征了一个亚群特异性DC表面分子（XCR1受体），DC上的其他分子由其他人定义。这些进步，加上细胞分离技术的改进，现在可以更好地表征人类原发性DC。在该项目中，我们打算完善目前对原代人血液DC抗原（交叉）递呈给T细胞的初步认识，并确定居住在淋巴组织和外周器官中的人DC的基本表型和免疫功能。这一信息将表明，在小鼠中发展的概念是否也适用于人类DC健康和（自身免疫性）疾病。获得的知识是我们和其他人未来开发新型疫苗的先决条件，其中通过在体内将抗原直接靶向XCR1+ DC来实现对肿瘤和细胞内病原体的细胞毒性免疫。